HIV infection and coronary heart disease: an intersection of epidemics

Area of Science:

• Cardiology
• Infectious Diseases
• Immunology

Background:

• Patients with human immunodeficiency virus (HIV) exhibit an elevated risk of coronary heart disease (CHD).
• Traditional CHD risk factors and antiretroviral medications are implicated, but inflammatory and immunologic factors play a central role in the complex mechanism.
• Understanding these factors is crucial for effective cardiovascular risk management in HIV-infected individuals.

Purpose of the Study:

• To review epidemiologic data on the association between HIV infection and CHD outcomes.
• To provide an overview of potential mechanistic factors contributing to CHD in HIV infection.
• To discuss strategies for managing CHD risk in HIV-infected patients.

Main Methods:

• Literature review of epidemiologic studies.
• Analysis of mechanistic factors related to inflammation and immunology in HIV-associated CHD.
• Synthesis of current strategies for CHD risk management in this population.

Main Results:

• HIV infection is strongly associated with increased CHD risk.
• Inflammatory and immunologic pathways are key contributors to CHD development in HIV.
• Management requires a dual approach: targeting traditional CHD risk factors and modulating immune/inflammatory processes.

Conclusions:

• Reducing CHD risk in HIV-infected patients necessitates addressing both traditional risk factors and immune/inflammatory dysregulation.
• Antiretroviral therapy and novel strategies may modify these factors.
• Comprehensive management strategies are essential for improving cardiovascular outcomes in HIV patients.